Recent Articles

• Brookdale Senior Living Plans Earnings Call for 2024 Results
• TransCode Therapeutics Delays Special Meeting for Vote Updates
• Manitowoc Company Expands Direct Crane Services Across States
• Lear Corporation Expands Automation Expertise with Acquisition
• Investigation into Quanterix Corporation Securities Practices
• Jeff Woolard Steps Into CFO Role at Cirrus Logic, Inc.
• Modine Posts Impressive Growth in Recent Fiscal Quarter
• Buenaventura's Milestone: $650 Million Notes Issuance Details
• Enova International Achieves Record Financial Performance
• Paralyzed Veterans of America Welcomes Doug Collins as VA Secretary
• Federated Hermes Elevates Kathryn Glass in Fixed-Income Leadership
• Dean Tucci Takes Stand Against CFPB, Seeks Justice in Court
• Medifast Set to Share Q4 and Annual Financial Performance
• Golden Entertainment's Upcoming Financial Results Announcement
• AdaptHealth Corp. Enhances Patient-Centered Services for 2024
• Olo Inc. Reveals Earnings Call Date for Q4 and FY 2024
• Teva Pharma's Path to Recovery: Understanding Market Position
• Champion Homes Reports Impressive Financial Growth in Q3
• Foundation Medicine's Partnership with Fulgent for Advanced Testing
• TriLink BioTechnologies Partners with Aldevron for mRNA Innovation
• Astria Therapeutics Unveils Stock Options for New Employees
• Lumen Technologies Shares Insights on 2024 and Future Prospects
• Arconic Corporation Investors: Join Class Action for Recovery
• Investors of Integral Ad Science Holding Corp. Urged to Act
• Grocery Outlet Investors Alert: Class Action Lawsuit Opportunity
• Omnicom Group Inc. Posts Strong Growth in 2024 Financials
• ModivCare Investors Get Chance to Lead Class Action Suit
• CCC Intelligent Solutions Prepares for Fourth Quarter Earnings
• Ambassador David Pressman Returns to Jenner & Block with Expertise
• QIAGEN Secures Court Win, Strengthening QuantiFERON Technology
• FMC Corporation 2024 Performance: Financial Highlights and Future Prospects
• Quince Therapeutics Secures Patent for Revolutionary A-T Treatment
• Huntington Bancshares to Showcase Strategies at UBS Event
• ASGN Incorporated Expands Reach with TopBloc Acquisition Strategy
• Jack Henry & Associates, Inc. Sees Growth in Fiscal Q2 2025
• Oscar Health's Impactful Performance in 2024: A Comprehensive Overview
• Q32 Bio Engages at Oppenheimer's 35th Healthcare Conference
• Nanoscope Therapeutics Set to Present at Key Medical Conferences
• Radiant Logistics Announces Investor Call on Financial Results
• Simon Property Group's Impressive Year-End Financial Report
• Pomerantz Law Firm Launches Investigation for Dave Inc. Investors
• Peoples Financial Services Corp. Announces New Leadership Roles
• Trinity Capital Inc. Reveals Key Financial Estimates for 2024
• Kulicke & Soffa Industries' First Quarter Review for 2025
• Syndax Pharmaceuticals Unveils Employee Stock Awards for Growth
• Aviat Networks Delivers Strong Fiscal Results in Second Quarter
• Cuyahoga Valley National Park Seeks New Leadership for Future Growth
• Integral Ad Science Corp. Lawsuit: Investor Rights and Options
• Legal Notice: Class Action Filed Against Applied Therapeutics
• Class Action Lawsuit Against Kaspi.kz: Investor Alert for KSPI